July 16, 2010 – Intrinsic Imaging LLC and Merge Healthcare announced this week that they have entered into a technology agreement and Intrinsic will become the first company to implement Merge’s new Clinical Imaging Management System (CIMS).

June 16, 2010 -- Dynamic EdgeT Gating Technology, the latest innovation of the Calypso System from Calypso Medical Technologies Inc., allows therapists to set motion thresholds which disable radiation delivery if the targeted tissue moves outside the preset threshold. The technology will be demonstrated at the 52nd Annual Meeting of the American Association of Physicists in Medicine, July 18-21.

July 16, 2010 – AMD Technologies Inc. this week announced the release of version 5.0 of the Catella PACS system, which features web-based diagnostic viewing.

July 16, 2010 – High demand has led Positron Corp. to increase production of Attrius positron emission tomography (PET) scanner with its joint venture, Neusoft Positron Medical Systems, the company announced recently.

July 14, 2010 -- Philips Radiation Oncology has launched a project to triple its engineering staff dedicated to cancer care technology solutions by July 2012. The project includes plans to more than double its workforce in the Madison area by July 2011.

July 14, 2010 – Devicor Medical Products Inc. announced this week the company completed the acquisition of Ethicon Endo-Surgery’s (EES) breast care business. The division sells products designed to help doctors diagnose breast cancer at early stages while minimizing patient discomfort. The business will formally be known as Mammotome, a division of Devicor.

July 12, 2010 – AngioDynamics announced today the global expansion of its Smart Port CT family of power-injectable ports, featuring its patented Vortex port technology, to include low-profile and mini models for repeated treatments such as chemotherapy and for use with computed tomography (CT).

July 12, 2010 – Lantheus Medical Imaging Inc. today announced that it has acquired the balance of the worldwide rights for gadofosveset trisodium, a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent that it currently markets in the United States as Ablavar.